490
Views
18
CrossRef citations to date
0
Altmetric
Reviews

Latest advances in the pathological understanding of cholangiocarcinomas

, &

References

  • Papers of special note have been highlighted as:
  • * of interest
  • ** of considerable interest
  • Nakanuma Y, Curado MP, Franceschi S Intrahepatic cholangiocarcinoma. In: Bosman FT, Carnoiro F, Hruba RH, et al., editors. WHO classification of tumors of the digestive system. Lyon: IARC Press; 2010. p. 217–224.
  • Nakanuma Y, Terada T, Tanaka Y, et al. Are hepatolithiasis and cholangiocarcinoma aetiologically related? A morphological study of 12 cases of hepatolithiasis associated with cholangiocarcinoma. Virchows Arch A Pathol Anat Histopathol. 1985;406:45–58.
  • Malhi H, Gores GJ. Cholangiocarcinoma: modern advances in understanding a deadly old disease. J Hepatol. 2006;45:856–867.
  • Reddy SB, Patel T. Current approaches to the diagnosis and treatment of cholangiocarcinoma. Curr Gastroenterol Rep. 2006;8:30–37.
  • Razumilava N, Gores GJ. Cholangiocarcinoma. Lancet. 2014;383:2168–2179.
  • Nakanuma Y, Kakuda Y. Pathologic classification of cholangiocarcinoma: new concepts. Best Pract Res Clin Gastroenterol. 2015;29:277–293.
  • Nakanuma Y, Kida T, Minato H, et al. Pathology of cholangiocellular carcinoma. In: Tobe T, Kameda H, Okudaira M, et al., editors. Primary liver cancer in Japan. Tokyo: Springer-Verlag; 1992. p. 39–50.
  • Deoliveira ML, Schulick RD, Nimura Y, et al. New staging system and a registry for perihilar cholangiocarcinoma. Hepatology. 2011;53:1363–1371.
  • Miyazaki M, Ohtsuka M, Miyakawa S, et al. Classification of biliary tract cancers established by the Japanese Society of Hepato-Biliary-Pancreatic Surgery: 3rd English edition. J Hepatobiliary Pancreat Sci. 2015;22:181–196.
  • Yamasaki S. Intrahepatic cholangiocarcinoma: macroscopic type and stage classification. J Hepatobiliary Pancreat Surg. 2003;10:288–291.
  • Nakanuma Y, Sato Y, Harada K, et al. Pathological classification of intrahepatic cholangiocarcinoma based on a new concept. World J Hepatol. 2010;2:419–427.
  • Zen Y, Adsay NV, Bardadin K, et al. Biliary intraepithelial neoplasia: an international interobserver agreement study and proposal for diagnostic criteria. Mod Pathol. 2007;20:701–709.
  • Zen Y, Aishima S, Ajioka Y, et al. Proposal of histological criteria for intraepithelial atypical/proliferative biliary epithelial lesions of the bile duct in hepatolithiasis with respect to cholangiocarcinoma: preliminary report based on interobserver agreement. Pathol Int. 2005;55:180–188.
  • Cardinale V, Carpino G, Reid L, et al. Multiple cells of origin in cholangiocarcinoma underlie biological, epidemiological and clinical heterogeneity. World J Gastrointest Oncol. 2012;4:94–102.
  • Nakanuma Y, Sasaki M, Ikeda H, et al. Pathology of peripheral intrahepatic cholangiocarcinoma with reference to tumorigenesis. Hepatol Res. 2008;38:325–334.
  • Kozaka K, Sasaki M, Fujii T, et al. A subgroup of intrahepatic cholangiocarcinoma with an infiltrating replacement growth pattern and a resemblance to reactive proliferating bile ductules: ‘bile ductular carcinoma’. Histopathology. 2007;51:390–400.

*Firstly described CCA resembling reactive bile ducts and referred this subtype to hepatic progenitor cells.

  • Cardinale V, Wang Y, Carpino G, et al. The biliary tree: a reservoir of multipotent stem cells. Nat Rev Gastroenterol Hepatol. 2012;9:231–240.

**First showed the presence of biliary tract stem cells in the peribiliary glands and their differentiation to pancreatic tissue and cholangiocytes.

  • Cardinale V, Wang Y, Carpino G, et al. Multipotent stem/progenitor cells in human biliary tree give rise to hepatocytes, cholangiocytes, and pancreatic islets. Hepatology. 2011;54:2159–2172.
  • Carpino G, Cardinale V, Onori P, et al. Biliary tree stem/progenitor cells in glands of extrahepatic and intrahepatic bile ducts: an anatomical in situ study yielding evidence of maturational lineages. J Anat. 2012;220:186–199.
  • Tsui WMS, Adsay NV, Crawford JM, et al. Mucinous cystic neoplasm of the liver. In: Bosman FT, Carnoiro F, Hruban RH, et al., editors. WHO classification of tumors of the digestive system. Lyon: IARC Press; 2010. p. 236–238.
  • Zen Y, Fujii T, Itatsu K, et al. Biliary cystic tumors with bile duct communication: a cystic variant of intraductal papillary neoplasm of the bile duct. Mod Pathol. 2006;19:1243–1254.

*First described a majority of biliary cystic neoplasm belong to intraductal papillary neoplasm of bile.

  • Matsubara T, Sato Y, Sasaki M, et al. Immunohistochemical characteristics and malignant progression of hepatic cystic neoplasms in comparison with pancreatic counterparts. Hum Pathol. 2012;43:2177–2186.
  • Zen Y, Jang KT, Ahn S, et al. Intraductal papillary neoplasms and mucinous cystic neoplasms of the hepatobiliary system: demographic differences between Asian and Western populations, and comparison with pancreatic counterparts. Histopathology. 2014;65:164–173.
  • Zamboni G, Fukushima N, Hruban RH, et al. Mucinous cystic neoplasms of the pancreas. In: Bosman FT, Carnoiro F, Hruba RH, et al., editors. WHO classification of tumors of the digestive system. Lyon: IARC Press; 2010. p. 281–291.
  • Terada T, Nakanuma Y. Pathological observations of intrahepatic peribiliary glands in 1,000 consecutive autopsy livers. II. A possible source of cholangiocarcinoma. Hepatology. 1990;12:92–97.
  • Nakanishi Y, Nakanuma Y, Ohara M, et al. Intraductal papillary neoplasm arising from peribiliary glands connecting with the inferior branch of the bile duct of the anterior segment of the liver. Pathol Int. 2011;61:773–777.
  • Nakanuma Y, Sato Y. Cystic and papillary neoplasm involving peribiliary glands: a biliary counterpart of branch-type intraductal papillary mucinous [corrected] neoplasm? Hepatology. 2012;55:2040–2041.
  • Sato Y, Harada K, Sasaki M, et al. Cystic and micropapillary epithelial changes of peribiliary glands might represent a precursor lesion of biliary epithelial neoplasms. Virchows Arch. 2014;464:157–163.

*First described the neoplastic lesions in the peribiliary glands and the relation of these lesions with pancreatic branch type IPMN.

  • Cardinale V, Wang Y, Carpino G, et al. Mucin-producing cholangiocarcinoma might derive from biliary tree stem/progenitor cells located in peribiliary glands. Hepatology. 2012;55:2041–2042.
  • Lim JH, Zen Y, Jang KT, et al. Cyst-forming intraductal papillary neoplasm of the bile ducts: description of imaging and pathologic aspects. AJR Am J Roentgenol. 2011;197:1111–1120.
  • Nakanuma Y, Harada K, Sasaki M, et al. Proposal of a new disease concept “biliary diseases with pancreatic counterparts.” Anatomical and pathological bases. Histol Histopathol. 2014;29:1–10.
  • Nakanuma Y. A novel approach to biliary tract pathology based on similarities to pancreatic counterparts: is the biliary tract an incomplete pancreas? Pathol Int. 2010;60:419–429.
  • Komuta M, Govaere O, Vandecaveye V, et al. Histological diversity in cholangiocellular carcinoma reflects the different cholangiocyte phenotypes. Hepatology. 2012;55:1876–1888.
  • Nakanuma Y, Sasaki M, Sato Y, et al. Multistep carcinogenesis of perihilar cholangiocarcinoma arising in the intrahepatic large bile ducts. World J Hepatol. 2009;1:35–42.
  • Nakanuma Y, Tsutsui A, Ren XS, et al. What are the precursor and early lesions of peripheral intrahepatic cholangiocarcinoma? Int J Hepatol. 2014;2014:805973.
  • Allaire GS, Rabin L, Ishak KG, et al. Bile duct adenoma. A study of 152 cases. Am J Surg Pathol. 1988;12:708–715.
  • Pinho AC, Melo RB, Oliveira M, et al. Adenoma-carcinoma sequence in intrahepatic cholangiocarcinoma. Int J Surg Case Reports. 2012;3:131–133.
  • Aishima S, Tanaka Y, Kubo Y, et al. Bile duct adenoma and von Meyenburg complex-like duct arising in hepatitis and cirrhosis: pathogenesis and histological characteristics. Pathol Int. 2014;64:551–559.
  • Nakanuma Y, Zen Y, Portman BC. Diseases of the bile duct. In: Burt BC, Ferrell LD, editors. MacSween’s pathology of the liver. Toronto (ON): Churchill Livingstone; 2012. p. 491–562.
  • Tsui WMS, Loo KT, Chow LTC, et al. Biliary adenofibroma: a heretofore unrecognized benign biliary tumor of the liver. Am J Surg Pathol. 1993;17:186–1923.
  • Akin O, Coskun M. Biliary adenofibroma with malignant transformation and pulmonary metastases: CT findings. Am J Roentgenol. 2002;179:280–281.
  • Tsutsui A, Bando Y, Sato Y, et al. Biliary adenofibroma with ominous features of imminent malignant changes. Clin J Gastroenterol. 2014;7:441–448.
  • Song JS, Lee YJ, Kim KW, et al. Cholangiocarcinoma arising in von Meyenburg complexes: report of four cases. Pathol Int. 2008;58:503–512.
  • Sempoux C, Fan C, Singh P, et al. Cholangiocellular carcinoma: an innocent-looking malignant liver tumor mimicking ductular reaction. Semin Liver Dis. 2011;3144:104–110.
  • Nakanuma Y, Sato Y, Ikeda H, et al. Intrahepatic cholangiocarcinoma with predominant “ductal plate malformation” pattern: a new subtype. Am J Surg Pathol. 2012;36:1629–1635.

*This is the first study describing ductal plate malformation structures in cholangiocarcinoma.

  • Nakanuma Y, Terada T, Ohta G, et al. Caroli’s disease in congenital hepatic fibrosis and infantile polycystic disease. Liver. 1982;2:346–354.
  • Chang YR, Lee KB, Jang JY, et al. Analysis of microscopic tumor spread patterns according to gross morphologies and suggestions for optimal resection margins in bile duct cancer. J Gastrointest Surg. 2014;18:1146–1154.
  • Itatsu K, Zen Y, Ohira S, et al. Immunohistochemical analysis of the progression of flat and papillary preneoplastic lesions in intrahepatic cholangiocarcinogenesis in hepatolithiasis. Liver Int. 2007;27:1174–1184.
  • Sasaki M, Yamaguchi J, Itatsu K, et al. Over-expression of polycomb group protein EZH2 relates to decreased expression of p16 INK4a in cholangiocarcinogenesis in hepatolithiasis. J Pathol. 2008;215:175–183.
  • Sato Y, Harada K, Sasaki M, et al. Histological characterization of biliary intraepithelial neoplasia with respect to pancreatic intraepithelial neoplasia. Int J Hepatol. 2014;2014:678260.
  • Albores-Saavedra J, Kloppel G, Adsay NV, et al. Carcinoma of the gallbladder and extrahepatic bile duct. In: Bosman FT, Carnoiro F, Hruba RH, et al., editors. WHO classification of tumors of the digestive system. Lyon: IARC Press; 2010. p.266–273
  • Sato Y, Sasaki M, Harada K, et al. Pathological diagnosis of flat epithelial lesions of the biliary tract with emphasis on biliary intraepithelial neoplasia. J Gastroenterol. 2014;49:64–72.

**Consensus report on the grade of biliary intraepithelial neoplasia and on practical algorism for the diagnosis.

  • Sakamoto E, Nimura Y, Hayakawa N, et al. The pattern of infiltration at the proximal border of hilar bile duct carcinoma: a histologic analysis of 62 resected cases. Ann Surg. 1998;227:405–411.
  • Konishi M, Iwasaki M, Ochiai A, et al. Clinical impact of intraoperative histological examination of the ductal resection margin in extrahepatic cholangiocarcinoma. Br J Surg. 2010;97:1363–1368.
  • Albores-Saavedra J, Murakata L, Krueger JE, et al. Noninvasive and minimally invasive papillary carcinomas of the extrahepatic bile ducts. Cancer. 2000;89:508–515.
  • Hoang MP, Murakata LA, Katabi N, et al. Invasive papillary carcinomas of the extrahepatic bile ducts: a clinicopathologic and immunohistochemical study of 13 cases. Mod Pathol. 2002;15:1251–1258.
  • Sato Y, Osaka H, Harada K, et al. Intraductal tubular neoplasm of the common bile duct: case report. Pathol Int. 2010;60:516–519.
  • Katabi N, Torres J, Klimstra DS. Intraductal tubular neoplasms of the bile ducts. Am J Surg Pathol. 2012;36:1647–1655.
  • Zen Y, Fujii T, Itatsu K, et al. Biliary papillary tumor share pathological features with intraductal papillary mucinous neoplasm of the pancreas. Hepatology. 2006;44:1333–1343.
  • Chen TC, Nakanuma Y, Zen Y, et al. Intraductal papillary neoplasia of the liver associated with hepatolithiasis. Hepatology. 2001;34:651–658.

*This is the first study of intraductal papillary neoplasm of bile duct showing similarity to pancreatic intraductal papillary mucinous neoplasm.

  • Rocha FG, Lee H, Katabi N, et al. Intraductal papillary neoplasm of the bile duct: a biliary equivalent to intraductal papillary mucinous neoplasm of the pancreas? Hepatology. 2012;56:1352–1360.
  • Minagawa N, Sato N, Mori Y, et al. A comparison between intraductal papillary neoplasms of the biliary tract (BT-IPMNs) and intraductal papillary mucinous neoplasms of the pancreas (P-IPMNs) reveals distinct clinical manifestations and outcomes. Eur J Surg Oncol. 2013;39:554–558.
  • Schlitter AM, Jang KT, Klöppel G, et al. Intraductal tubulopapillary neoplasms of the bile ducts: clinicopathologic, immunohistochemical, and molecular analysis of 20 cases. Mod Pathol. 2015;28:1249–1264.
  • Yamaguchi H, Kuboki Y, Hatori T, et al. The discrete nature and distinguishing molecular features of pancreatic intraductal tubulopapillary neoplasms and intraductal papillary mucinous neoplasms of the gastric type, pyloric gland variant. J Pathol. 2013;231:335–341.
  • Adsay NV, Kloppel G, Fukushima N, et al. Intraductal neoplasm of the pancreas. In: Bosman FT, Carnoiro F, Hruba RH, et al., editors. WHO classification of tumors of the digestive system. Lyon: IARC Press; 2010. p. 304–313.
  • Devaney K, Goodman ZD, Ishak KG. Hepatobiliary cystadenoma and cystadenocarcinoma. A light microscopic and immunohistochemical study of 70 patients. Am J Surg Pathol. 1994;18:1078–1091.
  • Ishak KG, Willis GW, Cummins SD, et al. Biliary cystadenoma and cystadenocarcinoma: report of 14 cases and review of the literature. Cancer. 1977;39:322–338.
  • Ishak KG, Goodman ZD, Stocker JT. Intrahepatic cholangiocarcinoma and other malignant biliary tumors. In: Tumors of the liver and intrahepatic bile ducts. Washington (DC): Atlas of Tumor Pathology, Armed Force Institute of Pathology; 2001. p. 245–270.
  • Terada T, Nakanuma Y, Ohta G. Glandular elements around the intrahepatic bile ducts in man; their morphology and distribution in normal livers. Liver. 1987;7:1–8.
  • Nakanuma Y, Sasaki M, Terada T, et al. Intrahepatic peribiliary glands of humans. II. Pathological spectrum. J Gastroenterol Hepatol. 1994;9:80–86.

**First review on the role and spectrum of the peribiliary glands in a variety of human biliary tract disease.

  • Igarashi S, Sato Y, Ren XS, et al. Participation of peribiliary glands in biliary tract pathophysiologies. World J Hepatol. 2013;5:425–432.
  • Carpino G, Cardinale V, Renzi A, et al. Activation of biliary tree stem cells within peribiliary glands in primary sclerosing cholangitis. J Hepatol. Forthcoming 2015.
  • Op Den Dries S, Westerkamp AC, Karimian N, et al. Injury to peribiliary glands and vascular plexus before liver transplantation predicts formation of non-anastomotic biliary strictures. J Hepatol. 2014;60:1172–1179.
  • Nakanuma Y, Hoso M, Sanzen T, et al. Microstructure and development of the normal and pathologic biliary tract in humans, including blood supply. Microsc Res Tech. 1997;38:552–570.
  • Hsu M, Sasaki M, Igarashi S, et al. KRAS and GNAS mutations and p53 overexpression in biliary intraepithelial neoplasia and intrahepatic cholangiocarcinomas. Cancer. 2013;119:1669–1674.
  • Gandou C, Harada K, Sato Y, et al. Hilar cholangiocarcinoma and pancreatic ductal adenocarcinoma share similar histopathologies, immunophenotypes, and development-related molecules. Hum Pathol. 2013;44:811–821.
  • Oikawa T, Kamiya A, Zeniya M, et al. Sal-like protein 4 (SALL4), a stem cell biomarker in liver cancers. Hepatology. 2013;57:1469–1483.
  • Sutton ME, Op Den Dries S, Koster MH, et al. Regeneration of human extrahepatic biliary epithelium: the peribiliary glands as progenitor cell compartment. Liver Int. 2012;32:554–559.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.